Detecting lung blood flow issues with a new ultrasound device
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial uses a non-invasive ultrasound device to detect abnormal blood flow connections in the lungs, which are common in people with hereditary hemorrhagic telangiectasia (HHT) or a type of stroke called cryptogenic stroke. The goal is to see if the device can find these issues safely and easily without needing an invasive procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have suspected or confirmed hereditary hemorrhagic telangiectasia (HHT), or you have had a cryptogenic stroke (a stroke with no known cause).
- You are not pregnant or breastfeeding.
- You do not have fractures or open skin injuries on the sides of your skull or near your temples.
- You do not have metal implants in your skull or head or ear shapes that might prevent the headset from fitting properly.
- You do not have known allergies to parabens, which are in the gel pad used with the device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to close a PFO (a small hole in the heart) in people who have had a stroke caused by a blood clot passing through that hole. The goal is to see if the device can prevent another stroke.
This trial tests a new device to close a PFO (a small hole between the upper chambers of the heart) in people who have had a stroke caused by a blood clot. The goal is to prevent future strokes by blocking the hole.
This trial uses a specialized ultrasound test (TEE with bubble study) to find a small opening in the heart called a PFO. It may help people who need this test to check for causes of certain health problems.
This trial tests a new 3D ultrasound technique to get clearer images of blood flow in the brain after a stroke, which could help doctors better understand and treat the damage.
This trial tests a new imaging system and tiny catheter that lets doctors see inside brain blood vessels more clearly during a planned angiogram. It may help people who need follow-up imaging after previous treatment or a diagnostic look at their vessels.
This trial uses a new ultrasound device (NeoDoppler) to watch blood flow in a baby's brain continuously. It aims to see if this gentle, bedside tool can help doctors monitor babies—especially those born early or with certain health concerns—without moving them.
Hear when a new Pulmonary Arteriovenous Malformation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.